Cargando…
LncRNA SNHG1 upregulates ROCK2 to reduce cisplatin sensitivity of NSCLC cells by targeting miR-101-3p
BACKGROUND: Cisplatin is the most commonly used chemotherapy drug in clinical settings, and decreased sensitivity or resistance to cisplatin is the main cause of chemotherapy failure or death among cancer patients. Long non-coding RNA (lncRNA) SNHG1 is highly expressed in non-small cell lung cancer...
Autores principales: | Wei, Lei, Yang, Nan, Sun, Lei, Zhang, Lei, Li, Zhongdong, Li, Demin, Qin, Tao, Huang, Hairong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798157/ https://www.ncbi.nlm.nih.gov/pubmed/35116964 http://dx.doi.org/10.21037/tcr.2019.09.24 |
Ejemplares similares
-
LncRNA SNHG7 promotes cardiac remodeling by upregulating ROCK1 via sponging miR-34-5p
por: Wang, Jie, et al.
Publicado: (2020) -
LncRNA SNHG6 Inhibits Apoptosis by Regulating EZH2 Expression via the Sponging of MiR-101-3p in Esophageal Squamous-Cell Carcinoma
por: Wang, Jiang, et al.
Publicado: (2020) -
Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2
por: Ye, Zhiqiang, et al.
Publicado: (2016) -
LncRNA SNHG14 contributes to the progression of NSCLC through miR‐206/G6PD pathway
por: Zhao, Lin, et al.
Publicado: (2020) -
LncRNA SNHG6 sponges miR-101 and induces tamoxifen resistance in breast cancer cells through induction of EMT
por: Khan, Mohammad Imran, et al.
Publicado: (2022)